Please assess the completion status of the following clinical trial:

Trial Title: To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. A new diagnosis of diabetic nephropathy proved by histology and(or) serology.~2. Proteinuria \> 2.5 g/24 h~3. serum creatinine \< 3 mg/dl~4. age 35-65 years~Exclusion Criteria:~1. Co-existence of anther chronic glomerular nephritis.~2. Severe disfunction of the liver~3. White blood cell \< 3000/ul~4. Severe infection in the past 1 month~5. Malignant hypertension which in hard to control~6. Myocardial infarct or heart failure or sever cerebral vessels complication in the past 6 month

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- immunosuppressor (Type: EXPERIMENTAL): Valsartan,160mg/d,TW 120mg/d

Based on this trial design, predict the completion outcome and termination type (if applicable).